The FDA approved the Guardant360 Liquid CDx circulating tumor DNA assay to detect ESR1 mutations in breast cancer patients.

552c7ae14Space

Health

Health news, debates, and claims covering public health, mental health, nutrition, medical care, and health policy.

1 debate·6,984 claims·43 news stories

0